Home › Diffuse Large B-Cell Lymphoma › Maryland › Baltimore
Diffuse Large B-Cell Lymphoma clinical trials in Baltimore, MD
5 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
RecruitingPhase 3
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RecruitingPhase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RecruitingObservational study
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RecruitingPhase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.